- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
OncoGenex Pharmaceutical Inc
+ Add to WatchlistOGXI:US
9.9800 USD 0.0500 0.50%As of 20:10:00 ET on 06/17/2013.
Snapshot for OncoGenex Pharmaceutical Inc (OGXI)
| Open: | 10.1500 | Day's Range: | 9.8800 - 10.1600 | Volume: | 37,355 |
|---|---|---|---|---|---|
| Previous Close: | 10.0300 | 52wk Range: | 9.1600 - 14.9888 | 1-Yr Rtn: | -22.99% |
Key Statistics for OGXI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -1.5400 |
| Est. EPS (USD) (12/2013) | -2.4180 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 146.41 |
| Shares Outstanding (M) | 14.67 |
| 30 Day Average Volume | 74,228 |
| Price/Book (mrq) | 2.4294 |
| Price/Sale (ttm) | 6.1235 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for OGXI
Company Profile & Key Executives for OGXI
OncoGenex Pharmaceutical Inc. is a biopharmaceutical company that develops and commercializes new cancer therapies that address treatment resistance in cancer patients.
| Scott CormackPresident/CEO | Cindy A JacobsExec VP/Chief Medical Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
OGXI News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page